Many investors welcomed the market’s recent decline as an opportunity to buy the dip. That’s not the best strategy, argue two ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific ...
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...
Biocodex, a global pharmaceutical company and long-time pioneer in the treatment of rare pediatric diseases, will present 12 studies at the upcoming AES 2025 Annual Meeting in Atlanta, Georgia, ...
US FDA accepts and grants priority review status to BeOne Medicines’ sonrotoclax to treat relapsed or refractory mantle cell lymphoma: San Carlos, California Friday, November 28 ...
Flatiron Health today announced its presence at the San Antonio Breast Cancer Symposium (SABCS) happening from December 9-12, 2025, in San Antonio, Texas. Flatiron's real-world data and research ...
(Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to a New Drug Application ...
Battlefield 6 devs recently announced that BF6 is getting a Free Trial Mode, giving players who don’t already own the game a chance to get some permanent progression and try the game out for free.
GameSpot may get a commission from retail offers. Battlefield Studios has announced a free trial for Battlefield 6, taking place over the Thanksgiving break for people in the US. The free trial runs ...
DICE is rolling out a major Battlefield 6 PS5 update today, which adds free content including a new map, mode, weapons, and more. Update 1.1.2.0 is billed as a “major” patch, which also makes changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback